In light of recent earnings trends, Nihon Chouzai Co., Ltd. announces to have revised full-year consolidated earnings forecast for the fiscal year ending March 31, 2021 released on October 30, 2020 as outlined below.
1. Revisions to full-year consolidated earnings forecast for fiscal year ending March 2021 (April 1, 2020 to March 31, 2021)
Net income
Net income per
Net sales
Operating profit
Ordinary profit
attributable to
share
owners of parent
Previously announced
Million yen
Million yen
Million yen
Million yen
Yen
forecast (A)
275,753
6,552
6,331
3,260
108.73
Revised forecast (B)
278,900
8,100
8,400
3,500
116.71
Change (B - A)
3,147
1,548
2,069
240
Change (%)
1.1%
23.6%
32.7%
7.4%
(Reference) Previous
FY actual
268,520
7,593
7,405
6,697
223.33
(FYE March 2020)
2. Reason for revision to earnings forecast
When formulating our previously revised full-year consolidated earnings forecast announced on October 30, 2020, we expected our various Group-wide measures to curtail expenses to continue to contribute to earnings performance and sales in the Pharmaceutical Manufacturing and Sales Business to remain strong. At the same time, we projected that the impacts of COVID-19 would persist throughout the year, which we believed would result in fewer prescriptions handled than initially forecast in the Dispensing Pharmacy Business.
Subsequently, pharmacy customer traffic made a stronger than expected recovery, sales of newly listed drugs in June and December 2020 in the Pharmaceutical Manufacturing and Sales Business continued to do well, and ongoing Groupwide cost reduction measures made additional contributions. As a result, sales and profits are now expected to exceed our previously revised forecasts. Hence, we decided to revise our full- year consolidated earnings forecast as presented above.
(Note) The abovementioned earnings forecasts are created based on currently available information and actual earnings may differ from these forecast figures due to any number of factors.
Furthermore, the number of issued shares used to calculate our forecast for net income per share is the currently assumed average number of shares for the full fiscal year.
Attachments
Original document
Permalink
Disclaimer
NIHON CHOUZAI Co. Ltd. published this content on 19 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 April 2021 00:13:07 UTC.
NIHON CHOUZAI Co., Ltd is primarily engaged in the pharmacy business, the provision of staffing services, as well as the manufacture and sale of pharmaceutical products. The Company operates in three business segments. The Pharmacy segment is engaged in the operation of a chain of dispensing pharmacies. The Pharmaceutical Product Manufacturing and Distribution segment is engaged in the manufacture and nationwide sale of generic pharmaceutical products. The Healthcare Personnel Staffing Service segment is involved in the dispatching of pharmacists to various regional pharmacies.
NIHON CHOUZAI CO.,LTD. 
